Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.21M Buy
6,955
+5,436
+358% +$962K 0.01% 275
2017
Q3
$283K Hold
1,519
﹤0.01% 350
2017
Q2
$260K Hold
1,519
﹤0.01% 379
2017
Q1
$249K Hold
1,519
﹤0.01% 395
2016
Q4
$222K Hold
1,519
﹤0.01% 393
2016
Q3
$253K Hold
1,519
﹤0.01% 392
2016
Q2
$234K Hold
1,519
﹤0.01% 388
2016
Q1
$228K Hold
1,519
﹤0.01% 393
2015
Q4
$247K Hold
1,519
﹤0.01% 374
2015
Q3
$210K Hold
1,519
﹤0.01% 371
2015
Q2
$233K Hold
1,519
﹤0.01% 384
2015
Q1
$243K Sell
1,519
-877
-37% -$138K ﹤0.01% 389
2014
Q4
$382K Hold
2,396
﹤0.01% 407
2014
Q3
$337K Sell
2,396
-6,754
-74% -$882K ﹤0.01% 442
2014
Q2
$1.08M Buy
+9,150
New +$1.06M 0.01% 441

Other funds holding AMGN

Virtus Fund Advisers's AMGN Position: Q4 2017 in Review

Virtus Fund Advisers increased its Amgen (AMGN) stake by 358% in Q4 2017, buying an estimated $962K and bringing the position to 6,955 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #275.

Virtus Fund Advisers first reported a position in AMGN in Q2 2014 and has held it in 15 quarters since. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Virtus Fund Advisers held 6,955 shares of Amgen worth $1.21M as of Q4 2017.
  • Virtus Fund Advisers bought 5,436 Amgen shares in Q4 2017, an estimated $962K.
  • Amgen made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #275 holding.
  • Virtus Fund Advisers first reported a position in Amgen in Q2 2014 and has held it in 15 quarters since.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.